RocketTickers

Jazz Pharmaceuticals Announces Positive Top-line Results

Long
NASDAQ:JAZZ   Jazz Pharmaceuticals plc
JAZZ: Jazz Pharmaceuticals plc
2019-03-26 16:13:00
Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness - PR Newswire
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.